Mark Larche
14Patents
3h-index
6Co-inventors
53Inventor score
Filing activity: Sep 21, 1994 → Oct 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5985280A | Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor | Chemistry; Metallurgy | 41 | Expired |
| US6156877A | Compounds for diagnosis and/or therapy of tumours | Chemistry; Metallurgy | 38 | Expired |
| US8652485B2 | Peptide for vaccine | Chemistry; Metallurgy | 14 | Active |
| US8551492B2 | Vaccine peptide combinations against cat allergy | Human Necessities | 3 | Active |
| US8491910B2 | Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy | Physics | 1 | Active |
| US9168295B2 | Vaccine peptide combinations | Human Necessities | 1 | Active |
| US8753644B2 | Grass peptides for vaccine | Human Necessities | 1 | Active |
| US8821887B2 | T-cell antigen peptide from allergen for stimulation of IL-10 production | Human Necessities | 0 | Active |
| US9017689B2 | Peptides for vaccine against birch allergy | Physics | 0 | Active |
| US9850281B2 | Cladosporium peptides | Physics | 0 | Active |
| US9340580B2 | Peptide with multiple epitopes | Chemistry; Metallurgy | 0 | Active |
| US6737406B1 | Cryptic peptides and method for their identification | Human Necessities | 0 | Expired |
| US9347937B2 | Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy | Physics | 0 | Active |
| US9744222B2 | Peptide for vaccine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.